Skip to content
healthcare.dev

Rolvedon

NDC 76961-101, eflapegrastim-xnst, injection, solution, from Spectrum Pharmaceuticals, Inc..

Product NDC
76961-101
Status
Listed
Labeler
Spectrum Pharmaceuticals, Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761148
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/76961-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EFLAPEGRASTIM13.2 mg/.6mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
76961-101-0176961010101.6 mL in 1 SYRINGE, GLASS (76961-101-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/6e436115-62e7-4729-aeb0-ff78ea685206
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=76961-101

Use it

Look up 76961-101 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/76961-101 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 76961-101. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.